Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;114(9):2329-2336.
doi: 10.1111/apa.70115. Epub 2025 May 7.

Long-Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis

Affiliations

Long-Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis

Monica S Ronconi et al. Acta Paediatr. 2025 Sep.

Abstract

Aim: Presence of deep ulcerations (DU) at diagnosis seems to be predictive of a more severe phenotype in adult Crohn's disease (CD). The aim of our study was to investigate if the presence of DU at diagnosis was associated with a more severe disease course over time in children.

Methods: In this monocentric retrospective study, we analysed data from paediatric patients with a new diagnosis of CD from 2009 to 2017. Clinical, laboratory data, treatments and complications were recorded for each patient at diagnosis and at 1, 3 and 5 years of follow-up. Patients were compared according to the presence or absence of DU on colonoscopy.

Results: Among the 116 patients included in the study, 52 patients had DU at diagnosis. Comparison showed an increased risk for patients with DU to develop abdominal abscesses (p = 0.045) and to experience more relapses (p = 0.013) at 1 year. At 3 and 5 years, there was no longer any difference between groups. The time from diagnosis to first anti-TNF alpha was shorter in DU patients.

Conclusion: The presence of DU at diagnosis is associated with more complications during the first year of follow-up but not after, due to a more active therapeutic management.

Keywords: IBD; children; endoscopy; prognostic factor; ulcerations.

PubMed Disclaimer

Conflict of interest statement

F.M.R. has received a consultation fee, research grant or honorarium from Janssen, Pfizer, Abbvie, Takeda, Celgene, Nestlé Health Science and Nestlé Nutrition Institute. B.P. has served as a speaker for Biocodex and Amgen. The other authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Deep ulcerations at colonoscopy.
FIGURE 2
FIGURE 2
Flowchart.
FIGURE 3
FIGURE 3
Time to first anti‐TNF alpha (survival curve, months).

References

    1. Peyrin‐Biroulet L., Sandborn W., Sands B. E., et al., “Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat‐To‐Target,” American Journal of Gastroenterology 110 (2015): 1324–1338, 10.1038/ajg.2015.233. - DOI - PubMed
    1. Turner D., Ricciuto A., Lewis A., et al., “STRIDE‐II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat‐To‐Target Strategies in IBD,” Gastroenterology 160 (2021): 1570–1583, 10.1053/j.gastro.2020.12.031. - DOI - PubMed
    1. Rosen M. J., Dhawan A., and Saeed S. A., “Inflammatory Bowel Disease in Children and Adolescents,” JAMA Pediatrics 169 (2015): 1053–1060, 10.1001/jamapediatrics.2015.1982. - DOI - PMC - PubMed
    1. Pigneur B., Seksik P., Viola S., et al., “Natural History of Crohn's Disease: Comparison Between Childhood‐ and Adult‐Onset Disease,” Inflammatory Bowel Diseases 16, no. 6 (2010): 953–961, 10.1002/ibd.21152. - DOI - PubMed
    1. Ruemmele F. M., Veres G., Kolho K. L., et al., “Consensus Guidelines of ECCO/ESPGHAN on the Medical Management of Pediatric Crohn's Disease,” Journal of Crohn's & Colitis 8, no. 10 (2014): 1179–1207, 10.1016/j.crohns.2014.04.005. - DOI - PubMed

Supplementary concepts